Clinical features and therapeutic outcomes of GH/TSH cosecreting pituitary adenomas: experience of a single pituitary center
N Yu, L Duan, F Hu, S Yang, J Liu, M Chen… - Frontiers in …, 2023 - frontiersin.org
Background Growth hormone (GH)/thyroid stimulating hormone (TSH) cosecreting pituitary
adenoma (PA) is an exceedingly rare kind of bihormonal pituitary neuroendocrine tumors …
adenoma (PA) is an exceedingly rare kind of bihormonal pituitary neuroendocrine tumors …
Endoscopic endonasal pituitary surgery for nonfunctioning pituitary adenomas: long-term outcomes and management of recurrent tumors
AL Bernat, P Troude, SM Priola, A Elsawy, F Farrash… - World Neurosurgery, 2021 - Elsevier
Introduction Endoscopic endonasal approaches (EEAs) provide improved access and
operative visualization for resection of pituitary adenomas. Although the technique has …
operative visualization for resection of pituitary adenomas. Although the technique has …
[HTML][HTML] Presentation, management, and outcomes of nonfunctioning pituitary adenomas: an experience from a developing country
B Das, S Batool, A Khoja, N Islam - Cureus, 2019 - ncbi.nlm.nih.gov
Objective The goal of this study was to evaluate the presentation, management, and clinical
outcome of nonfunctioning pituitary adenomas (NFPAs) in a tertiary care setup. Methods We …
outcome of nonfunctioning pituitary adenomas (NFPAs) in a tertiary care setup. Methods We …
Non-functioning pituitary macroadenomas: factors affecting postoperative recurrence, and pre-and post-surgical endocrine and visual function
V Subramanian, RSM Lee, S Howell, S Gregson… - Endocrine, 2021 - Springer
Background Non-functioning pituitary macroadenomas (NFPAs) with visual field defects are
ideally managed by transsphenoidal tumour resection to improve vision, and long-term …
ideally managed by transsphenoidal tumour resection to improve vision, and long-term …
Subclinical hemorrhagic nonfunctionning pituitary adenoma: pituitary gland function status, endoscopic endonasal transsphenoidal surgery, and outcomes
M Wang, Y Jiang, Y Cai, H Wu… - British Journal of …, 2023 - Taylor & Francis
Objective How do subclinical hemorrhages into nonfunctioning pituitary adenomas (NFPAs)
influence the hormonal status and surgical outcomes remains unclear, our study aim at …
influence the hormonal status and surgical outcomes remains unclear, our study aim at …
Differentiating between non-functioning pituitary macroadenomas and sellar meningiomas using ADC
J Zhang, Z Zhao, L Dong, T Han, G Zhang… - Endocrine …, 2020 - ec.bioscientifica.com
Introduction and aim: It is difficult to distinguish between non-functioning pituitary
macroadenomas (NFPMAs) and sellar meningiomas because of their overlapping imaging …
macroadenomas (NFPMAs) and sellar meningiomas because of their overlapping imaging …
[PDF][PDF] A review of treatment efficacy, side effects and follow-up of surgery and radiosurgery in patients with acromegaly
S KAMIAN, R PIRDEHGHAN… - Journal of Complementary …, 2022 - jocmr.com
Background: Acromegaly is an infrequent disorder where the body generates excessive
growth hormone (GH) and other growth factors such as insulin-like agents. If remain …
growth hormone (GH) and other growth factors such as insulin-like agents. If remain …
[PDF][PDF] Evaluation of surgery and radiosurgery for acromegaly: A review of efficacy, complications, and follow-up
S KAMIAN, R PIRDEHGHAN, A NAJMALDIN - pjmhsonline.com
Background: Acromegaly is a rare disease caused by an over-increase in growth hormone
(GH) and insulin-like growth factors. If left untreated, acromegaly is associated with many …
(GH) and insulin-like growth factors. If left untreated, acromegaly is associated with many …